Search for: "Matter of Regen"
Results 81 - 100
of 214
Sort by Relevance
|
Sort by Date
21 Feb 2019, 1:14 pm
It is the top recipient of funds from the California Institute for Regenerative Medicine (CIRM), as the agency is formally known. [read post]
19 Feb 2019, 12:28 pm
At the top of the matter is the fact that the state agency expects to run out of cash for new awards by the end of this year. [read post]
4 Feb 2019, 2:01 am
Estar counterclaimed that Regen's patent was invalid. [read post]
13 Jan 2019, 6:44 am
Newsom was busy last week with non-stem cell matters, such as a $209 billion budget he laid out for lawmakers. [read post]
22 Nov 2018, 9:00 am
Does it matter that the consultation is with a California doctor? [read post]
26 Jun 2018, 1:55 pm
"At the time of this posting, the agency, formally known as the California Institute of Regenerative Medicine (CIRM), had not added online any background material supporting the cryptic, agenda item. [read post]
'Spontaneity' Live: A Powerful, Cyberspace PR Tool for California's Cash-Strapped Stem Cell Program?
10 Jun 2018, 9:19 pm
The agency's "value proposition" is not well understood, say officials at the agency, formally known as the California Institute for Regenerative Medicine (CIRM). [read post]
29 May 2018, 12:32 pm
Missing from the news, however, was any mention of the agency's multimillion-dollar contribution -- a not insignificant matter since the agency is facing its own financial demise in less than two years. [read post]
7 May 2018, 3:34 pm
Although the agency tends to focus strongly on medical and scientific achievements, today's PR hit had a stronger emphasis on business matters. [read post]
2 May 2018, 1:10 am
Notice of opposition was filed against the granted patent, the opponent requesting revocation of the patent in its entirety on the grounds of lack of novelty and inventive step (Articles 54(2) and 56 EPC and Article 100(a) EPC), lack of sufficiency of disclosure (Article 100(b) EPC) and added subject-matter (Article 100(c) EPC).III. [read post]
2 May 2018, 1:10 am
Notice of opposition was filed against the granted patent, the opponent requesting revocation of the patent in its entirety on the grounds of lack of novelty and inventive step (Articles 54(2) and 56 EPC and Article 100(a) EPC), lack of sufficiency of disclosure (Article 100(b) EPC) and added subject-matter (Article 100(c) EPC).III. [read post]
Media Coverage of Stem Cell Therapy for Blindness Loses Sight of California's $36 Million in Support
6 Apr 2018, 1:00 am
But only if the agency is mentioned in the news coverage.Public perceptions are no small matter for supporters of the research agency, formally known as the California Institute for Regenerative Medicine (CIRM). [read post]
27 Mar 2018, 12:05 pm
They used M2 macrophages specifically because of their high regenerative potential and anti-inflammatory activity. [read post]
6 Mar 2018, 3:00 am
Californians throughout the state next week will have what appears to be a record number of opportunities to participate -- albeit remotely -- in one of the more important, regular public meetings involving the $3 billion state stem cell agency.The occasion is the March 13 meeting of the governing board of what is known formally as the California Institute for Regenerative Medicine or CIRM. [read post]
23 Feb 2018, 2:30 am
Here is a link to the CIRM blog item on the matter. [read post]
21 Feb 2018, 7:41 am
MiMedx Group, Inc. incorporated on February 28, 2008, is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone, according to its website. [read post]
12 Jan 2018, 9:09 am
Its "disclosure" did not deal with such matters as the fact that it is the first such enterprise in state history or that it operates outside of the purview of the governor and the legislature. [read post]
22 Dec 2017, 4:51 pm
Los Angeles $1,701,178DISC2-10714iPS Glial Therapy for White Matter Stroke and Vascular DementiaStanley Thomas CarmichaelU.C. [read post]
13 Dec 2017, 9:20 pm
The California Institute for Regenerative Medicine (CIRM), as the agency is formally known, expects to run out of cash for new awards in 2019.Tuszynski's comment was also unusual. [read post]
6 Dec 2017, 9:32 am
More information is expected to be posted in the next few days, but it is likely to resemble closely the matters discussed in late November by the directors. [read post]
